Objective:As part of the national Be Clear on Cancer campaign, the ‘blood in pee’ campaign was launched in 2013. We aimed to evaluate the impact of the campaign on 2-week wait (2WW) referrals and the resulting diagnoses of malignancy at a single trust, and secondly, to evaluate the socio-economic background of patients referred.Patients and methods:Suspected cancer 2WW patients in the 3 months pre- and post-campaign were included. Demographics, investigations and diagnoses were recorded. A Kolmogorov–Smirnov test demonstrated a normal distribution. The data were treated as parametric and analysed with the unpaired Student’s t-test.Results:Referrals for visible haematuria significantly increased by 52% from 135 pre-campaign to 205 post-campa...
OBJECTIVE: We report NHS England data for patients with bladder cancer (BC), upper tract urothelial ...
BACKGROUND: Following referral for investigation of urgent suspected cancer within the English Natio...
Objectives To develop and validate tests to assess the risk of any cancer for patients referred to t...
AIM: To evaluate the impact of the national 'Be Clear on Cancer' bowel cancer reminder campaign on s...
AIM:To evaluate the impact of the national 'Be Clear on Cancer' bowel cancer reminder campaign on se...
Objective: A regional ‘Be Clear on Cancer’ (BCoC) campaign developed by Public Health England aimed ...
Rapid diagnostic centres (RDCs) are being implemented across the UK to accelerate the assessment of ...
This is the final version. Available on open access from Springer Nature via the DOI in this record....
For some common cancers, survival is lower in the UK than in comparable high-income countries. To as...
Background: Cancer outcomes are poor in socioeconomically deprived communities, with low symptom awa...
Purpose: Secondary prevention programmes have traditionally employed mass screening approaches to as...
This is the final version. Available on open access from the Royal College of General Practitioners ...
Aim In 2003, the West of Scotland Cancer Awareness Programme (WoSCAP) launched their oral cancer cam...
BACKGROUND: Stage at diagnosis strongly predicts cancer survival and understanding related inequalit...
Objective To evaluate the ‘Call for a Kit’ health promotion intervention that was initiated in Lanca...
OBJECTIVE: We report NHS England data for patients with bladder cancer (BC), upper tract urothelial ...
BACKGROUND: Following referral for investigation of urgent suspected cancer within the English Natio...
Objectives To develop and validate tests to assess the risk of any cancer for patients referred to t...
AIM: To evaluate the impact of the national 'Be Clear on Cancer' bowel cancer reminder campaign on s...
AIM:To evaluate the impact of the national 'Be Clear on Cancer' bowel cancer reminder campaign on se...
Objective: A regional ‘Be Clear on Cancer’ (BCoC) campaign developed by Public Health England aimed ...
Rapid diagnostic centres (RDCs) are being implemented across the UK to accelerate the assessment of ...
This is the final version. Available on open access from Springer Nature via the DOI in this record....
For some common cancers, survival is lower in the UK than in comparable high-income countries. To as...
Background: Cancer outcomes are poor in socioeconomically deprived communities, with low symptom awa...
Purpose: Secondary prevention programmes have traditionally employed mass screening approaches to as...
This is the final version. Available on open access from the Royal College of General Practitioners ...
Aim In 2003, the West of Scotland Cancer Awareness Programme (WoSCAP) launched their oral cancer cam...
BACKGROUND: Stage at diagnosis strongly predicts cancer survival and understanding related inequalit...
Objective To evaluate the ‘Call for a Kit’ health promotion intervention that was initiated in Lanca...
OBJECTIVE: We report NHS England data for patients with bladder cancer (BC), upper tract urothelial ...
BACKGROUND: Following referral for investigation of urgent suspected cancer within the English Natio...
Objectives To develop and validate tests to assess the risk of any cancer for patients referred to t...